月旦知識庫
 
  1. 熱門:
 
首頁 臺灣期刊   法律   公行政治   醫事相關   財經   社會學   教育   其他 大陸期刊   核心   重要期刊 DOI文章
TAIWAN EPIDEMIOLOGY BULLETIN 本站僅提供期刊文獻檢索。
  【月旦知識庫】是否收錄該篇全文,敬請【登入】查詢為準。
最新【購點活動】


篇名
Epidemiology and Molecular Diagnosis of Leprosy, Taiwan, 2002-2016
並列篇名
Epidemiology and Molecular Diagnosis of Leprosy, Taiwan, 2002-2016
作者 Wei-Lun HuangRuwen Jou (Ruwen Jou)
英文摘要
The World Conference on Leprosy, held in 2016, reaffirmed the importance of stopping transmission, preventing disability, and detecting cases early in eradicating the disease. In Taiwan, leprosy is rare and the prevalence rate has reached the eradication criteria. Among the 133 confirmed cases in 2002-2016, 79(59.4%) were female, with 61(72.6%) imported, and the proportion of imported female cases was significant higher than that of the indigenous female cases (p < 0.0001). Since M. leprae cannot be cultured in vitro, bacilli should be inoculated in BALB/c mouse's foot pads. For drug resistance testing, quantitative bacilli are inoculated within a foot pad, and the mice were fed with drug-containing food for 30 weeks. After that, the mice were sacrificed, and the amounts of bacteria were calculated. In order to improve the effectiveness of laboratory diagnosis, we establish an algorithm with molecular tests to identify M. leprae and its drug resistance since 2013. During 2013-2016, of the 47 suspected cases, 27(57.4%) cases were analyzed using the molecular tests. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 95.2%, 100%, 100%, 85.7% and 96.3%, respectively. The laboratory tests can strengthen the disease control and management.
起訖頁 133-133
關鍵詞 LeprosyMycobacterium lepraeMolecular diagnosisDrug-resistance analysis
刊名 TAIWAN EPIDEMIOLOGY BULLETIN  
期數 20171024 (33:20期)
出版單位 衛生福利部疾病管制署
該期刊-上一篇 Status of Laboratory Diagnosis on Tuberculosis, Taiwan, 2015
該期刊-下一篇 Disease Surveillance Express: week 39-41
 

新書閱讀



最新影音


優惠活動




讀者服務專線:+886-2-23756688 傳真:+886-2-23318496
地址:臺北市館前路28 號 7 樓 客服信箱
Copyright © 元照出版 All rights reserved. 版權所有,禁止轉貼節錄